Adrenal Hyperplasia Among Young People With PCOS
NCT01313455 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 96
Last updated 2019-05-31
Summary
Background:
\- Polycystic ovarian syndrome (PCOS) is a group of disorders related to problems with the secretion of certain hormones, which can lead to reproductive and other issues in women. Frequent complications of PCOS include irregular menstruation, development of ovarian cysts, and insulin resistance. The adrenal glands, which sit on top of the kidney, are involved in the production of certain hormones and the regulation of steroid levels in the blood, and may be affected in women with PCOS. Researchers are interested in studying possible connections between the adrenal glands and PCOS in young women who have been diagnosed with PCOS and healthy volunteers with normal menstrual function.
Objectives:
\- To investigate possible connections between adrenal gland steroid hormone secretion and polycystic ovarian syndrome.
Eligibility:
* Women between 16 and 29 years of age who have been diagnosed with PCOS, or who are healthy volunteers with normal menstrual function.
* Participants must be willing to discontinue the use of oral contraceptives or any other medications that alter steroid hormone production for at least 1 month before the start of the study.
Design:
* Participants will be screened with a physical examination, medical history, and blood and urine tests. All participants will also have a pelvic (ovarian) ultrasound.
* All participants will be admitted to the hospital for a 1-week testing period, which will involve the following tests:
* Regular blood draws for two 2-hour periods (late evening and early morning) to measure hormone levels
* Fasting blood draws with a dose of corticotropin to test the body's adrenal function
* Hormone level measurement following regular doses of dexamethasone (a drug that controls the function of the adrenal gland)
* Daily urine collection for 6 days.
* Other studies, such as imaging studies of the adrenal glands, may be conducted as required by the study researchers.
Conditions
- Adrenal Hyperplasia
- Polycystic Ovarian Syndrome
- Oligomenorrhea
- Obesity
- Hyperandrogenism
Sponsors & Collaborators
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
lead NIH
Principal Investigators
-
Maya B Lodish, M.D. · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Eligibility
- Min Age
- 16 Years
- Max Age
- 29 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-03-10
- Completion
- 2017-10-24
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and Stimulation
NCT01421797 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Metabolic Disorders in Polycystic Ovarian Syndrome
NCT00172523 ·Status: UNKNOWN
-
History of Exposure to Endocrine Disruptors in Women With Polycystic Ovary Syndrome
NCT04998448 ·Status: UNKNOWN
-
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
NCT03905603 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome
NCT03911297 ·Status: RECRUITING
-
Endocrine, Metabolic and Inflammatory Characteristics of Offspring of Mothers With PCOS Hyperandrogenism
NCT06371313 ·Status: COMPLETED
-
Study of Metabolism and Cardiovascular Disease(CVD) in Women With Polycystic Ovary Syndrome (PCOS)
NCT01117558 ·Status: COMPLETED
-
Theca Cell Function in Women With Polycystic Ovary Syndrome (PCOS)
NCT00747617 ·Status: COMPLETED ·Phase: PHASE3
-
Anxiety and Depression in Adolescent PCOS
NCT07127458 ·Status: COMPLETED ·Phase: NA
-
Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
NCT01840618 ·Status: COMPLETED
-
Environmental Factors in the Development of Polycystic Ovary Syndrome
NCT00341731 ·Status: COMPLETED
-
Effect of Hyperandrogenism on IVF Outcomes in PCOS Patients
NCT05555680 ·Status: TERMINATED
-
A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens
NCT05370521 ·Status: TERMINATED ·Phase: PHASE2
-
Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS
NCT03252223 ·Status: COMPLETED ·Phase: PHASE4
-
Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism
NCT01360996 ·Status: COMPLETED ·Phase: PHASE4
-
Research Study for Children With a Mother or Sister With Polycystic Ovary Syndrome
NCT00559390 ·Status: COMPLETED
-
PCOS Twin Study - Environmental Factors in the Development of Polycystic Ovary Syndrome, Phase 2
NCT00444288 ·Status: COMPLETED
-
Impact of 11-oxygenated Androgens on Metabolic Dysfunction of Women With Polycystic Ovary Syndrome
NCT05246865 ·Status: UNKNOWN ·Phase: NA
-
Subcutaneous Adipose Tissue in Cases With Polycystic Ovarian Syndrome
NCT01310569 ·Status: COMPLETED
-
Blood Vessel Function in Adolescents and Women With Polycystic Ovary Syndrome
NCT01615562 ·Status: TERMINATED
-
Ovarian Morphology in Girls
NCT04424576 ·Status: RECRUITING
-
Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOS
NCT01482286 ·Status: TERMINATED ·Phase: PHASE3
-
Obesity and Clinical Presentation of Hyperandrogenism
NCT01114633 ·Status: COMPLETED
-
Reproductive Axis Maturation in the Early Post-Menarchal Years
NCT03986021 ·Status: RECRUITING
-
Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea
NCT00696111 ·Status: COMPLETED ·Phase: NA